in a 2-year , randomized , double-blind nordic multicentre trial , auranofin was compared with placebo in early ( disease duration less than or equal to 2 years ) , active rheumatoid arthritis ( ra ) .
C0004320
auranofin
C0003873
rheumatoid arthritis